版本:
中国

BRIEF-Cumberland Pharmaceuticals says caldolor demonstrates significant post surgical pain reduction and decrease in opioid use

March 28 Cumberland Pharmaceuticals Inc

* Cumberland Pharmaceuticals Inc says Caldolor demonstrates significant post surgical pain reduction and decrease in opioid use Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐